Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Correction to: BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
Journal: Circulation
Published: April 28, 2025
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial.
Journal: BMJ open respiratory research
Published: January 24, 2023
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.
Journal: The Journal of clinical investigation
Published: May 16, 2022
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19.
Journal: The European respiratory journal
Published: March 05, 2021
Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study.
Journal: Pulmonary circulation
Published: January 05, 2021
Comparison of Fixed-Dose Inhaled Epoprostenol and Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome in Critically Ill Adults.
Journal: Journal of intensive care medicine
Published: March 06, 2020
Capillary Proliferation in Systemic-Sclerosis-Related Pulmonary Fibrosis: Association with Pulmonary Hypertension.
Journal: ACR open rheumatology
Published: November 29, 2019
Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill.
Journal: The Annals of pharmacotherapy
Published: September 24, 2019
A 75-Year-Old Man With Organizing Pneumonia Presenting With Worsening Dyspnea.
Journal: Chest
Published: April 21, 2019
A review of exercise pulmonary hypertension in systemic sclerosis.
Journal: Journal of scleroderma and related disorders
Published: December 10, 2018
Last Updated: 09/26/2026